The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales
Rheumatology (Oxford). 2017 Jun 1;56(6):1049.
doi: 10.1093/rheumatology/kex218.
1 The Kellgren Centre for Rheumatology, NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust.
2 Arthritis Research UK Centre for Epidemiology.
3 Division of Musculoskeletal & Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester.
4 Department of Medicine, Addenbrooke's Hospital, Cambridge.
5 Department of Rheumatology, Freeman Hospital, Newcastle upon Tyne.
6 Division of Rheumatology, University College London, Rayne Institute, London.
7 Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham.
8 Rheumatology Department, City Hospital, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham.
9 Louise Coote Lupus Unit, Guys Hospital, London.
10 Rheumatology Department-University Hospitals Birmingham NHS Foundation Trust, Old Queen Elizabeth Hospital, Birmingham.
11 Rheumatology Department, Nottingham University Hospitals NHS Trust, Nottingham.
12 Leeds Institute for Rheumatic and Musculoskeletal Medicine, University of Leeds.
13 NIHR Leeds Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds.
14 Department of Rheumatology, Doncaster and Bassetlaw Hospitals NHS Foundation Trust, Doncaster.
15 Musculoskeletal Research Unit, NIHR Wellcome Trust Clinical Research facility, The University of Southampton.
16 University Hospital Southampton NHS Foundation Trust, Southampton, UK.
17 Department of Rheumatology, Royal Blackburn Hospital, Blackburn.
18 Rheumatology Department, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield.
19 Department of Rheumatology, Royal National Hospital for Rheumatic Diseases and Royal United Hospitals Bath NHS Foundation Trust.
20 Department of Pharmacy and Pharmacology, University of Bath, Bath.